胰腺癌嗜神经侵袭与神经重塑的研究历史和治疗现状

doi:10.16139/j.1007-9610.2022.01.011

摘要/Abstract

中图分类号:

R735.9

卫积书, 黄诗朦. 胰腺癌嗜神经侵袭与神经重塑的研究历史和治疗现状[J]. 外科理论与实践, 2022, 27(01): 42-45.

WEI Jishu, HUANG Shimeng. Perineural invasion and neural plasticity in pancreatic cancer: study history and current treatment[J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 42-45.

参考文献 34

[1]	Batsakis JG. Nerves and neurotropic carcinomas[J]. Ann Otol Rhinol Laryngol, 1985, 94(4 Pt 1):426-427.
[2]	Liebig C, Ayala G, Wilks JA, et al. Perineural invasion in cancer: a review of the literature[J]. Cancer, 2009, 115(15):3379-3391. doi: 10.1002/cncr.24396 URL
[3]	Demir IE, Friess H, Ceyhan GO. Neural plasticity in pancreatitis and pancreatic cancer[J]. Nat Rev Gastroenterol Hepatol, 2015, 12(11):649-659. doi: 10.1038/nrgastro.2015.166 URL
[4]	Demir IE, Ceyhan GO, Liebl F, et al. Neural invasion in pancreatic cancer: the past, present and future[J]. Cancers (Basel), 2010, 2(3):1513-1527. doi: 10.3390/cancers2031513 URL
[5]	Fouquet T, Germain A, Brunaud L, et al. Is perineural invasion more accurate than other factors to predict early recurrence after pancreatoduodenectomy for pancreatic head adenocarcinoma?[J]. World J Surg, 2014, 38(8):2132-2137. doi: 10.1007/s00268-014-2465-7 URL
[6]	Nagakawa T, Mori K, Nakano T, et al. Perineural invasion of carcinoma of the pancreas and biliary tract[J]. Br J Surg, 1993, 80(5):619-621. doi: 10.1002/bjs.1800800526 URL
[7]	Nagakawa T, Kayahara M, Ueno K, et al. Clinicopathological study on neural invasion to the extrapancreatic nerve plexus in pancreatic cancer[J]. Hepatogastroenterology, 1992, 39(1):51-55.
[8]	Kayahara M, Nagakawa T, Ueno K, et al. Surgical strategy for carcinoma of the pancreas head area based on clinicopathologic analysis of nodal involvement and plexus invasion[J]. Surgery, 1995, 117(6):616-623. doi: 10.1016/S0039-6060(95)80003-4 URL
[9]	Nakao A, Harada A, Nonami T, et al. Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer[J]. Pancreas, 1996, 12(4):357-361. doi: 10.1097/00006676-199605000-00006 URL
[10]	Yi SQ, Miwa K, Ohta T, et al. Innervation of the pancreas from the perspective of perineural invasion of pancreatic cancer[J]. Pancreas, 2003, 27(3):225-229. doi: 10.1097/00006676-200310000-00005 URL
[11]	Demir IE, Boldis A, Pfitzinger PL, et al. Investigation of Schwann cells at neoplastic cell sites before the onset of cancer invasion[J]. J Natl Cancer Inst, 2014, 106(8): dju184.
[12]	Ceyhan GO, Bergmann F, Kadihasanoglu M, et al. Pancreatic neuropathy and neuropathic pain--a comprehensive pathomorphological study of 546 cases[J]. Gastroenterology, 2009, 136(1):177-186. doi: 10.1053/j.gastro.2008.09.029 URL
[13]	Ceyhan GO, Demir IE, Rauch U, et al. Pancreatic neuropathy results in“neural remodeling” and altered pancreatic innervation in chronic pancreatitis and pancreatic cancer[J]. Am J Gastroenterol, 2009, 104(10):2555-2565. doi: 10.1038/ajg.2009.380 URL
[14]	Iwasaki T, Hiraoka N, Ino Y, et al. Reduction of intrapancreatic neural density in cancer tissue predicts poorer outcome in pancreatic ductal carcinoma[J]. Cancer Sci, 2019, 110(4):1491-1502. doi: 10.1111/cas.13975 URL
[15]	Kawarada Y. New classification of pancreatic carcinoma--Japan Pancreas Society[J]. Nihon Shokakibyo Gakkai Zasshi, 2003, 100(8):974-980.
[16]	Pedrazzoli S, Dicarlo V, Dionigi R, et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group[J]. Ann Surg, 1998, 228(4):508-517. pmid: 9790340
[17]	Farnell MB, Pearson RK, Sarr MG, et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma[J]. Surgery, 2005, 138(4):618-628,628-630. doi: 10.1016/j.surg.2005.06.044 URL
[18]	Michalski CW, Kleeff J, Wente MN, et al. Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer[J]. Br J Surg, 2007, 94(3):265-273. doi: 10.1002/bjs.5716 URL
[19]	Nimura Y, Nagino M, Takao S, et al. Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas: long-term results of a Japanese multicenter randomized controlled trial[J]. J Hepatobiliary Pancreat Sci, 2012, 19(3):230-241. doi: 10.1007/s00534-011-0466-6 URL
[20]	Jang JY, Kang MJ, Heo JS, et al. A prospective rando-mized controlled study comparing outcomes of standard resection and extended resection, including dissection of the nerve plexus and various lymph nodes, in patients with pancreatic head cancer[J]. Ann Surg, 2014, 259(4):656-664. doi: 10.1097/SLA.0000000000000384 URL
[21]	Demir IE, Schorn S, Schremmer-Danninger E, et al. Pe-rineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitis[J]. PLoS One, 2013, 8(3):e60529. doi: 10.1371/journal.pone.0060529 URL
[22]	Demir IE, Kujundzic K, Pfitzinger PL, et al. Early pancreatic cancer lesions suppress pain through CXCL12-mediated chemoattraction of Schwann cells[J]. Proc Natl Acad Sci USA, 2017, 114(1):e85-e94.
[23]	Damm M, Weniger M, Kolsch AK, et al. The quality of pain management in pancreatic cancer: a prospective multi-center study[J]. Pancreatology, 2020, 20(7):1511-1518. doi: 10.1016/j.pan.2020.08.017 URL
[24]	Okusaka T, Okada S, Ueno H, et al. Abdominal pain in patients with resectable pancreatic cancer with reference to clinicopathologic findings[J]. Pancreas, 2001, 22(3):279-284. doi: 10.1097/00006676-200104000-00009 URL
[25]	Sahin IH, Shama MA, Tanaka M, et al. Association of diabetes and perineural invasion in pancreatic cancer[J]. Cancer Med, 2012, 1(3):357-362. doi: 10.1002/cam4.43 URL
[26]	Deandrea S, Montanari M, Moja L, et al. Prevalence of undertreatment in cancer pain. A review of published li-terature[J]. Ann Oncol, 2008, 19(12):1985-1991. doi: 10.1093/annonc/mdn419 pmid: 18632721
[27]	Greco MT, Roberto A, Corli O, et al. Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer[J]. J Clin Oncol, 2014, 32(36):4149-4154. doi: 10.1200/JCO.2014.56.0383
[28]	Drewes AM, Campbell CM, Ceyhan GO, et al. Pain in pancreatic ductal adenocarcinoma: a multidisciplinary, international guideline for optimized management[J]. Pancreatology, 2018, 18(4):446-457. doi: 10.1016/j.pan.2018.04.008 URL
[29]	Sakamoto H, Kitano M, Kamata K, et al. EUS-guided broad plexus neurolysis over the superior mesenteric artery using a 25-gauge needle[J]. Am J Gastroenterol, 2010, 105(12):2599-2606. doi: 10.1038/ajg.2010.339 pmid: 20823834
[30]	Luz LP, Al-Haddad MA, Dewitt JA. EUS-guided celiac plexus interventions in pancreatic cancer pain: An update and controversies for the endosonographer[J]. Endosc Ultrasound, 2014, 3(4):213-220. doi: 10.4103/2303-9027.144515 URL
[31]	Bang JY, Sutton B, Hawes RH, et al. EUS-guided celiac ganglion radiofrequency ablation versus celiac plexus neurolysis for palliation of pain in pancreatic cancer: a randomized controlled trial[J]. Gastrointest Endosc, 2019, 89(1):58-66. doi: 10.1016/j.gie.2018.08.005 URL
[32]	Saloman JL, Albers KM, Li D, et al. Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer[J]. Proc Natl Acad Sci USA, 2016, 113(11):3078-3083. doi: 10.1073/pnas.1512603113 URL
[33]	Demir IE, Reyes CM, Alrawashdeh W, et al. Clinically actionable strategies for studying neural influences in cancer[J]. Cancer Cell, 2020, 38(1):11-14. doi: 10.1016/j.ccell.2020.05.023 URL
[34]	Saloman JL, Albers KM, Rhim AD, et al. Can stopping nerves, stop cancer?[J]. Trends Neurosci, 2016, 39(12):880-889. doi: S0166-2236(16)30139-4 pmid: 27832915

胰腺癌嗜神经侵袭与神经重塑的研究历史和治疗现状

Perineural invasion and neural plasticity in pancreatic cancer: study history and current treatment

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 34

相关文章 15

编辑推荐

Metrics

本文评价

[1]	朱颖, 汤玉茗, 黄佳, 章永平, 姚玮艳. 全反式维A酸可促进肿瘤相关诱导配体对多种胰腺癌细胞的凋亡作用[J]. 内科理论与实践, 2023, 18(03): 171-176.
[2]	杨蕊馨, 杜宇童, 燕然林, 朱正纲, 李琛, 于颖彦. 消化道肿瘤单细胞转录组测序研究中生物样本前处理改良的探索[J]. 诊断学理论与实践, 2022, 21(05): 567-574.
[3]	何敏, 刘颖斌. 可切除胰腺癌的判断标准与治疗及其争议[J]. 外科理论与实践, 2022, 27(01): 6-10.
[4]	吴莉莉, 许耀麟, 楼文晖. 放射治疗在胰腺癌治疗中的应用现状和展望[J]. 外科理论与实践, 2022, 27(01): 25-29.
[5]	王冲, 程石. 可切除胰腺癌术前减黄的共识与争议[J]. 外科理论与实践, 2022, 27(01): 30-33.
[6]	李晓丽, 李为光, 钱爱华, 曹国良. 胰腺癌血清微RNA-486-3p的异常表达及对细胞增殖、凋亡的影响[J]. 内科理论与实践, 2021, 16(02): 121-125.
[7]	罗丹阳, 高益鸣. 口腔菌群与胰腺癌的相关性研究进展[J]. 外科理论与实践, 2021, 26(01): 84-86.
[8]	丁方谜, 刘振东. 叉头盒蛋白D1激活细胞外信号调节激酶通路促进胰腺癌侵袭转移[J]. 外科理论与实践, 2020, 25(06): 486-492.
[9]	钱梨寒, 沈柏用. 局部进展期胰腺癌综合治疗的研究进展[J]. 外科理论与实践, 2020, 25(05): 442-446.
[10]	吴璟奕, 李国静, 费健. 以急性胰腺炎为首发表现的胰腺癌（附17例报告）[J]. 外科理论与实践, 2020, 25(04): 326-330.
[11]	孙文韬, 邓侠兴. 胰腺癌与乙型肝炎感染的研究进展[J]. 外科理论与实践, 2020, 25(02): 171-173.
[12]	张超, 王伟艺, 唐文皓. 自噬在胰腺癌及其治疗中作用的研究进展[J]. 外科理论与实践, 2019, 24(06): 555-559.
[13]	薛美琳, 陈皓. 内镜超声检查及相关技术在胰腺癌诊治的应用[J]. 外科理论与实践, 2019, 24(06): 565-568.
[14]	严诚, 倪小艳, 姚秀忠, 陈财忠, 顾君英. 自由呼吸弥散加权磁共振成像在自身免疫性胰腺炎与胰腺癌诊断中的应用分析[J]. 外科理论与实践, 2019, 24(03): 230-235.
[15]	傅宁稹, 王伟珅, 詹茜, 沈柏用. 胰周淋巴系统概况及在胰腺癌治疗中的意义[J]. 外科理论与实践, 2019, 24(03): 276-280.